Lucira Health (NASDAQ:LHDXQ) Versus Navidea Biopharmaceuticals (NYSE:NAVB) Head to Head Review
Lucira Health (NASDAQ:LHDXQ) Versus Navidea Biopharmaceuticals (NYSE:NAVB) Head to Head Review
Lucira Health (NASDAQ:LHDXQ – Get Rating) and Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.
Lucira Health（納斯達克股票代碼：LHDXQ — 獲取評級）和Navidea Biopharmaceuticals（紐約證券交易所代碼：NAVB — 獲取評級）都是小型醫療公司，但哪隻是優勢股？我們將根據分析師建議的強度、機構所有權、股息、盈利能力、估值、風險和收益對這兩家企業進行比較。
Earnings and Valuation
收益和估值
This table compares Lucira Health and Navidea Biopharmaceuticals' revenue, earnings per share (EPS) and valuation.
該表比較了Lucira Health和Navidea Biopharmaceuticals的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | 0.08 | -$64.83 million | ($3.58) | -0.05 |
| Navidea Biopharmaceuticals | $70,000.00 | 135.53 | -$15.18 million | ($0.56) | -0.52 |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| 露西拉健康 | 9306 萬美元 | 0.08 | -6,483 萬美元 | (3.58 美元) | -0.05 |
| Navidea 生物製藥 | 70,000.00 美元 | 135.53 | -1,518 萬美元 | (0.56 美元) | -0.52 |
Navidea Biopharmaceuticals has lower revenue, but higher earnings than Lucira Health. Navidea Biopharmaceuticals is trading at a lower price-to-earnings ratio than Lucira Health, indicating that it is currently the more affordable of the two stocks.
Navidea Biopharmaceuticals的收入較低，但收益高於Lucira Health。Navidea Biopharmaceuticals的市盈率低於Lucira Health的市盈率，這表明它目前是這兩隻股票中更實惠的一隻。
Insider & Institutional Ownership
內幕和機構所有權
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 5.6% of Navidea Biopharmaceuticals shares are held by institutional investors. 30.4% of Lucira Health shares are held by insiders. Comparatively, 45.2% of Navidea Biopharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Lucira Health的57.0％股份由機構投資者持有。相比之下，Navidea Biopharmaceuticals的5.6％股票由機構投資者持有。Lucira Health的30.4％的股票由內部人士持有。相比之下，Navidea Biopharmaceuticals有45.2％的股票由內部人士持有。強大的機構所有權表明，大型基金經理、捐贈基金和對沖基金認爲股票有望實現長期增長。
Analyst Recommendations
分析師建議
This is a summary of current recommendations and price targets for Lucira Health and Navidea Biopharmaceuticals, as provided by MarketBeat.com.
這是Marketbeat.com提供的Lucira Health和Navidea Biopharmaceuticals當前的建議和目標價格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Navidea Biopharmaceuticals | 0 | 0 | 0 | 0 | N/A |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不適用 |
| Navidea 生物製藥 | 0 | 0 | 0 | 0 | 不適用 |
Risk & Volatility
風險與波動性
Lucira Health has a beta of 3.36, suggesting that its share price is 236% more volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500.
Lucira Health的beta值爲3.36，這表明其股價的波動性比標準普爾500指數高236％。相比之下，Navidea Biopharmaceuticals的beta值爲1.5，這表明其股價的波動性比標準普爾500指數高50％。
Profitability
盈利能力
This table compares Lucira Health and Navidea Biopharmaceuticals' net margins, return on equity and return on assets.
該表比較了Lucira Health和Navidea Biopharmaceuticals的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Navidea Biopharmaceuticals | N/A | N/A | -362.74% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| Navidea 生物製藥 | 不適用 | 不適用 | -362.74% |
Summary
摘要
Navidea Biopharmaceuticals beats Lucira Health on 6 of the 11 factors compared between the two stocks.
比較兩隻股票的11個因素中，Navidea Biopharmaceuticals在6個因素上擊敗了Lucira Health。
About Lucira Health
關於 Lucira Health
(Get Rating)
（獲取評級）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家醫療技術公司。它專注於變革性和傳染病檢測試劑盒的開發和商業化。Lucira Health Inc. 總部位於加利福尼亞州的埃默裏維爾。
About Navidea Biopharmaceuticals
關於 Navidea BioParmaceuticals
(Get Rating)
（獲取評級）
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
Navidea Biopharmaceuticals, Inc. 從事精密免疫診斷藥物和免疫療法的開發和商業化。它通過以下部門運營：診斷、治療和企業。該公司成立於1983年，總部位於俄亥俄州都柏林。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Lucira Health及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。